Cheiny Shiau, PA
Medical · Los Angeles, CANPI 1477036895
Payments from drug & device makers
Across 1,330 payments — averaging $64.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$33K
- UCB, Inc.$15K
- Galderma Laboratories, L.p.$15K
- Arcutis Biotherapeutics, Inc.$6K
- Sanofi$3K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $13K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 423 | $32,803 |
| UCB, Inc. | 152 | $14,547 |
| Galderma Laboratories, L.p. | 54 | $14,511 |
| Arcutis Biotherapeutics, Inc. | 65 | $6,294 |
| Sanofi | 59 | $2,558 |
| E.r. Squibb & Sons, L.L.C. | 94 | $2,248 |
| Novartis | 72 | $1,961 |
| Amgen | 56 | $1,794 |
| Regeneron Healthcare Solutions, Inc. | 43 | $1,570 |
| Lilly USA, LLC | 53 | $1,511 |
| Dermavant Sciences, Inc. | 31 | $1,299 |
| Pfizer | 74 | $1,206 |
| Sun Pharmaceutical Industries Inc. | 20 | $760 |
| Johnson & Johnson | 28 | $714 |
| Incyte Corporation | 22 | $677 |
| LEO Pharma Inc. | 22 | $507 |
| Journey Medical Corporation | 18 | $461 |
| Verrica Pharmaceuticals Inc. | 10 | $241 |
| Sanofi-aventis U.S. LLC | 2 | $198 |
| Mayne Pharma Commercial LLC | 17 | $134 |
| Organon | 4 | $120 |
| Boehringer Ingelheim | 2 | $68 |
| Fresenius Kabi USA, LLC | 2 | $56 |
| Argenx US, Inc. | 1 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $31 |
| Botanix SB Inc | 1 | $25 |
| Dermira, Inc. | 1 | $25 |
| LNHC, Inc | 1 | $20 |
| Almirall LLC | 1 | $17 |
| Sandoz | 1 | $14 |
How this compares
$86,404 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Los Angeles
- Jeffrey BonnaudLos Angeles$314K
- Kenny Davis TrinidadLos Angeles$99K
- Xochitl RentelnLos Angeles$38K
- Charlotte CarlsonLos Angeles$30K
- Dorna YaghoobzadehLos Angeles$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Ana TorresLaguna Beach$229K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.